Toward novel vaccines and therapies based on negative-strand RNA viruses.

Abstract excerpt

The study of negative-strand RNA viruses has suggested new strategies to produce more attenuated viruses. Reverse genetics has allowed the implementation of the strategies, and new or improved monovalent vaccines are being developed. In addition, recombinant viruses expressing foreign proteins or epitopes have been produced with the aim of developing multivalent vaccines capable of stimulating humoral and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Engineering
• Share to Genetic Vectors
• Share to Immunotherapy